Intracellular accumulation of AAV6 genomes governs microglia reactivity and the inflammatory response in retinal gene therapy
Pereira, A.; Ducloyer, J.-B.; Demilly, J.; Toublanc, E.; Libeau, L.; Robert, B.; Mellet, A.; Augereau, D.; Comtesse, L.; Larcher, T.; Lebreton, A.; Socheleau, P.; Grard, M.; Journou, M.; Couzinie, C.; Blouin, V.; Weber, M.; Le Meur, G.; Le Guiner, C.; Adjali, O.; Cronin, T.
Show abstract
Adeno-associated viral (AAV) vectors possess immense potential for gene therapy applications. However, microglia can mount an immune response against AAV vectors. Yet, microglia are therapeutic targets since they play a driving role in the progression of neurodegenerative diseases. Thus, it is critical to understand the cellular processes driving the microglia-mediated immune response against AAV vectors. To this end, we modelled AAV6 induced inflammation upon retinal gene therapy in minipigs. Upon AAV6 administration, the IBA1+ cells demonstrated a morphological transition to the amoeboid form, indicating microglial reactivity. We also observed the invasion of peripheral immune cells in the retina. To elucidate the underlying molecular mechanisms, we transduced human iPSC derived microglia-like cells (iMGLs) in vitro with AAV6 and AAV8 respectively. Only AAV6 transduced iMGLs exhibited morphological features and a transcriptomic signature of microglial reactivity. The magnitude of intracellular AAV6 viral genomes was significantly higher as compared to the AAV8 condition. The elevated levels of intracellular AAV6 genomes induced a DNA damage response in AAV6-transduced iMGLs, which is a key feature of neuroinflammation-linked microglial reactivity. Thus, our work highlights the impact of intracellular viral genome accumulation on microglial reactivity and its implications for retinal gene therapy associated inflammation.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Optimizing AAV2/6 microglial targeting identified enhanced efficiency in the photoreceptor degenerative environment 94%
- Systemic and local immune response to intraocular AAV vector administration in non-human primates 93%
- Outcomes of Progranulin Gene Therapy in the Retina are Dependent on Time of Delivery 92%
Similar papers in this journal
- A novel multiplex RNAi therapy simultaneously targets Hif1a and Hif2a to defy retinal degeneration in two models of AMD 93%
- Exogenous Photoreceptor-Specific N-Glycosylated PROM1 Rescues Retinal Degeneration in Patient and Mouse Models 92%
- Functional repair after ischemic injury through high efficiency in situ astrocyte-to-neuron conversion 92%
Similar papers in this journal
- New AAV9 engineered variants with enhanced neurotropism and reduced liver off-targeting in mice and marmosets 92%
- Simple and Highly Specific Targeting of Resident Microglia with Adeno-Associated Virus 91%
- Comparison of immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines for SARS-CoV-2 90%
Similar papers in this journal
- Single intravitreal administration of a tetravalent siRNA exhibits robust and efficient gene silencing in rodent and swine photoreceptors 92%
- AAVone: A Cost-Effective, Single-Plasmid Solution for Efficient AAV Production with Reduced DNA Impurities 91%
- Antisense oligonucleotide allele-specific targeting of EFEMP1 in a patient-derived model of Doyne honeycomb retinal dystrophy 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.